Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,766 GBX | +2.11% | -0.45% | +21.81% |
Jun. 01 | Delaware judge lets more than 70,000 Zantac lawsuits go forward | RE |
Jun. 01 | GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal | RE |
Evolution of the average Target Price on GSK plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering GSK plc
Goldman Sachs | |
LBBW | |
Jefferies & Co. | |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
JEFFERIES | Peter Welford |
Bernstein | |
BERNSTEIN RESEARCH | Justin Smith |
DZ BANK | Elmar Kraus |
UBS | |
alphavalue | Abhishek Raval |
JPMORGAN | James Gordon |
Barclays | |
BERENBERG | Kerry Holford |
Guggenheim | |
Citigroup | |
Deutsche Bank Securities | |
Morgan Stanley | |
Berenberg Bank | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
Bank of America Securities/Merrill Lynch | |
Stifel Nicolaus | |
ODDO BHF | |
Societe Generale | |
Liberum Capital | |
J.P. Morgan Chase | |
DEUTSCHE BANK | Emmanuel Papadakis |
KEPLER CHEUVREUX | David Evans |
BAADER BANK | |
SVB Leerink | |
BANK OF AMERICA (BOFA) | Graham Parry |
EPS Revisions
- Stock Market
- Equities
- GSK Stock
- Consensus GSK plc